ALL
Warning: Undefined variable $taxName in /home/itamarmedi/domains/itamar-medical.com/public_html/wp-content/themes/itamar-theme/archive-articles.php on line 51

WatchPAT® 300 Initialization 
FTDI Drivers Installation
ITAMARTM MEDICAL
ITAMARmc MEDICAL
End-of-Life Notice for EndoPAT2000™ in Japan
NOTIFICATION OF PRODUCT DISCONTINUATION WATCHPAT 200 UNIFIED HOME SLEEP APNEA TEST – (For US)
Live Webinar – Best practices to efficiently screen for sleep apnea in your cardiology practice
ZOLL remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional Use
Obstructive sleep apnea severity predicts atherosclerotic plaque burden
Sleep Apnea, Gut Health, and Hypertension: Exploring the Link
Poor quality sleep can lead to diabetes
Can Treating OSA Reduce Dementia Risk?
How Dentists (and Oral Appliances for Sleep Apnea) Can Help Save Marriages
Adequate CPAP Use Reduces Cardiovascular Risk After Acute Coronary Syndrome: The RICCADSA Trial
Home Sleep Apnea Testing Should Be Required Prior to Atrial Fibrillation Catheter Ablation
Taking Patients With Atrial Fibrillation on a VIRTUAL-SAFARI With WatchPAT® ONE At-Home Sleep Apnea Testing
Itamar® Medical’s PAT Academy
Nonobese patients with obstructive sleep apnea: what is the effect of low respiratory arousal threshold (LRAT)?
Is sleep apnea in women underdiagnosed and undertreated?
Central Sleep Apnea Worsens Throughout the Night in People with Heart Failure
Maxillomandibular advancement (MMA) surgery and obstructive sleep apnea (OSA)
How knowledgeable are dentists about OSA?
WatchPAT Central PLUSTM Central Without Effort
Study: “People with sleep apnea live longer on CPAP”
Exploring the relationship between sleep disorders and RA
Dental sleep medicine and COVID: How bruxism is affecting patients
Obstructive Sleep Apnea is an Independent Risk Factor for MI Following Off-Pump CABG
Double the odds? Sleep apnea can mean twice the risk of sudden death.
Dental Sleep Physicians Step Up After Philips’ CPAP Recall
WatchPAT300®️ Firmware Update Instructions
Adding CPAP to Gestational Diabetes Management: A Step Before Insulin?
2021 AHA Recommendations on Obstructive Sleep Apnea
Hispanic Study OSA
African American Men OSA
Can rising COVID cases increase incidence of obstructive sleep apnea?
Sleep-Disordered Breathing Predicts Morbidity and Mortality in Heart Failure Patients
WatchPAT Scoring Guideline Webinar
CPAP Reduces Long-Term Cardiovascular Risk in Patients with Obstructive Sleep Apnea
Study Spotlight
Body position and sleep stage: misclassifying sleep apnea severity?
Beyond AHI
Revised AF Screening Recommendations for Patients With OSA: European Society of Cardiology (2020) Guidelines
Study Spotlight
CPAP and Cardiovascular Outcomes: Time for a Closer Look
WatchPAT®️ 300 Initialization – zzzPAT Users Only
Study Spotlight
Itamar Medical Survey Points at-home Sleep Apnea Testing Trends, COVID Impact
Comorbid Insomnia and Obstructive Sleep Apnea: Double Trouble
Link between obstructive sleep apnea and some cancers?
Academy statement: “Sleep is a biological necessity…essential to health.”
CLINICAL SPOTLIGHT: Review of Pollak and Povitz’s Editorial
Trucking Companies Deliver Sleep Apnea Relief to Drivers
Sleep Disorders and Atrial Fibrillation: What We Know
A Closer Look at the Visible Signs of Sleep Apnea
What sleep clinicians should know about the National Sleep Foundation’s Sleep Health Index
Can Sleep Disorders Lead to Hypertension?
Sleep in America poll results: a wakeup call for sleep apnea diagnoses
CMS Reimbursement: Update & Frequently Asked Questions
Looking Forward – Life’s Essential 8?
Looking Back at Life’s Simple 7
Leverage Your Advantages to Elevate Your Role in Your Patients’ Overall Health
Why Dental Experts Recommend Obstructive Sleep Apnea Screenings Be Part of Your Dental Practice
A New Year’s Resolution: Better Sleep for Better Cardiovascular Health
WatchPAT®  300 Initialization 
Engineering a Strong Finish to 2020 While Looking Ahead
OSA and Diabetes: Severing the Link with Awareness and Proactive Screening
Sleep trackers measure how long – but what about how well?
WatchPAT: Proven to Detect Residual Sleep-Disordered Breathing in Patients on CPAP
How WatchPAT ONE Is Adjusted for Success in the COVID 19 Era
5 Questions with Itamar Medical CEO Gilad Glick
Covid 19 and the Reshaping of the Sleep Apnea Clinic Model
Screening Questionnaires Fail to Predict Sleep Apnea in Patient with Atrial Fibrillation
ESRS the European Sleep Research Society Annual Meeting
Sleep Testing Is Evolving. How Will It Look In the Near Future?
Heart Failure, Sleep Apnea, and the WatchPAT TurnKey
zzzPAT®️ SW Version 5.3.81 (for Japan)
 zzzPAT®️ SW Version 5.3.82.4 (for Japan)
 zzzPAT®️ SW Version 5.3.82.5
Itamar™ Medical and BetterNight to Join Forces Offering Referred Patients Home Based Virtual-Care Sleep Solution for the Diagnosis and Treatment of Sleep Apnea
Itamar™ Medical Implements Broad Range of Actions in Response to COVID-19 Pandemic
Itamar™ Medical Reports Record Fourth Quarter and Full Year 2019 Revenues
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence
Itamar™ Medical to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 3, 2020
Itamar™ Medical to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 3, 2020
Itamar™ Medical Announces Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT®️ Device in Diagnosing Sleep Apnea
Itamar™ Medical Announces Closing of Upsized Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
Itamar™ Medical Announces Upsizing and Pricing of Public Offering of American Depositary Shares
ZOLL Announces Closing of Acquisition of Itamar Medical
Itamar™ Medical Announces Proposed $30 Million Offering of American Depositary Shares
Itamar™ Medical Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 and Revenue Guidance for Full Year 2020
Itamar Medical™ Selected to Participate in the Prestigious Weizmann Institute Project 10K
Piper Jaffray Healthcare Conference
Itamar™ Medical and SoClean® Announce Collaboration to Offer WatchPAT®️ ONE and other Digital Health Services Through Direct-to-Consumer Channels
Third Quarter 2019 Financial Results
Itamar™ Medical reports record third quarter 2019 revenues
Itamar™ Medical to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019
Itamar™ Medical to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 26, 2019
ItamarTM Medical Announces Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include WatchPATTM in Their Policies
Itamar™ Medical Appoints Jennifer Cook, MD, FAHA, FACC, as Global Medical Director
Release of New White PAT®️ Probe
Itamar™ Medical Advances Simple, Accurate and Reliable Home Sleep Apnea
Ladenburg Thalmann 2019 Healthcare Conference
Itamar™ Medical to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019
Second Quarter 2019 Financial Results
Notification of Product Discontinuation WatchPAT 200 Unified Home Sleep Apnea Test Outside of the US 
Itamar™ Medical Reports Record Second Quarter 2019 Revenues
Itamar™ Medical to Report Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 14, 2019
Approved Cleaning Products for WatchPAT®️ Devices
SLEEP CARDIOLOGY REVIEW
New CloudPAT®️ SW version 2.8
Itamar™ Medical WatchPAT®️ One 510k Clearance Final
Notification of Product Discontinuation WatchPAT®️ Non-Unified Probe
Itamar™ Medical reports first quarter 2019 financial results
Itamar™ Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT®️ 300
Itamar™ Medical Reports Fourth Quarter And Full Year 2018 Financial Results With Record Revenues
Itamar™ Medical to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
Itamar™ Medical to Commence Trading on Nasdaq
Itamar™ Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review
Itamar™ Medical Partners with CardioVisual to Educate Patients and Healthcare Providers on the Importance of Sleep Apnea Testing and Streamline Cardiology Practice Workflow
Impact of OSA on Abdominal Aortic Aneurysm
Itamar™ Medical Announces Definitive Agreements for $11.5 Million Private Placement
How OSA increase the risk of bradyarrhythmias
Itamar™ Medical Reports Record Third Quarter 2018 Financial Results
Bidirectional association between OSA and Patent Foramen Ovale
The Future of Home Sleep Apnea Testing
The association of OSA with cardiovascular outcomes after percutaneous coronary intervention: A new meta-analysis
Coding and Billing for Unattended Sleep Studies
Itamar™ Medical Reports Second Quarter 2018 Financial Results
Itamar™ Medical Announces Favorable CMS Reimbursement Decision to its WatchPAT®️ Sleep Apnea Testing Device
The Complex Interaction Between Heart Failure and OSA
OSA and AFib Association – A New Review
Itamar®️ Medical reports record financial results for the first quarter, with 26% increase in revenue to $5.5 million and minimal operating loss
Itamar™ Medical Launches SleePath®️, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool for AFib Patients at Heart Rhythm 2018
Itamar Medical Highlights New WatchPAT®️ Scoring Guidelines Based on the COMPASS(1) Study Results from Johns Hopkins Sleep Investigators at SLEEP 2018
New Insights on the Mechanisms by which OSA Increase Risk of Stroke
Itamar™ Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss.
The Unexpected Role of OSA Treatment in SCD, Risk Stratification and Prevention
New Insights into Afib ablation: Can sleep apnea fill in the gap?
Airway Management announced a new partnership with Itamar®️ Medical Ltd to distribute the myTAP oral appliance.
Newsletter 35 – December 2017
Sleep Apnea Test | Home Sleep Apnea Testing by Itamar Medical
The Potential Pathophysiological Mechanisms of Obstructive Sleep Apnea that may be a major contributor to AFib disease progression
Effective Hypertension Control Starts at Home
How Electrophysiologists Reduce AFib Recurrence by Addressing Sleep Apnea
Barriers to sleep medicine integration into cardiology care
The Clinical Relevance of Sleep Disordered Breathing to Cardiology Care
FDA clearance for the new WatchPAT®️ Central Plus
Itamar™ Medical BioTelemetry Collaboration
EndoPAT®️ system may help measure cardiovascular risk from breast cancer treatment
Itamar™ Medical Reports Success in Clinical Study Validating WatchPAT®️ for Central Sleep Apnea Differentiation, Submits Application for FDA Clearance of New WatchPAT®️ Version
End of Life Notice of the Old Version SBP
ItamarTM Medical Offers a Total Sleep Apnea Management Solution to Cardiologists
End of Life Notice of the WatchPAT200 SN: 3xxxx Model as of January 1, 2016
New Agreement Puts Itamar™ Medical Inc. and Arterial Health International (AHI)
Galmed Pharmaceuticals and Itamar®️ Medical to Collaborate on Assessing Aramchol’s Effect on Endothelial Function.
Itamar™ Medical Signs an Exclusive Distribution Agreement with Nihon Kohden Japan for Its EndoPAT Device
Itamar™ Medical Launches WatchPAT®️ Unified
Itamar™ Launches New Cloud Service
Yelin Lapidot and Migdal Insurance to Invest NIS 23.6 Million in Itamar Medical in a Private Equity Placement New Agreement Puts Itamar®️ Medical Inc. and Arterial Health International (AHI)
Validating the Watch PAT for Diagnosing Obstructive Sleep Apnea in Adolescents
End-of-life note for Watch-PAT100 product
Cardio Sleep Review 3
Cardio Sleep Review 2
Oppenheimer 29th Annual Healthcare Conference
Newsletter 34 – November 2017
Newsletter 33 – March 2017
Japan Newsletter Volume 2
Japan Newsletter Volume 1
Newsletter 32 – July 2016
CONTACT US
To reach our customer support please send an email to [email protected]
Data Protection
PRIVACY POLICY FOR END USERS
PRIVACY POLICY FOR WEBSITE VISITORS & BUSINESS CONTACTS
Cookie Policy
Terms and Conditions of Sale
Itamar Medical License Agreement
Home Sleep Apnea Test
Itamar Medical - Home Sleep Testing Company Profile
WatchPAT Home Sleep Study Device
Endothelial Dysfunction
Itamar Medical: Medical Device Company & Manufacturer
Diagnosing Sleep Apnea
CONTACT US
© ZOLL Itamar Ltd.
Site by Imaginet
© Itamar Medical Ltd.
Site by Imaginet

When using the marks in our publications and this website, we used the appropriate ™️, ℠, or ®️. The ®️ symbol is used to indicate registrations in the U.S. and the territories listed in https://www.itamar-medical.com/terms-and-conditions/ and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®️ is a trademark of Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners., registered in the U.S. and the applicable territories listed inhttps://www.itamar-medical.com/terms-and-conditions/ only.

Menu